Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Apollo Hospitals Enterprise's interest expense for the
three
months ended in Mar. 2026 was ₹ -1,191 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-4,496 Mil.
Apollo Hospitals Enterprise (BOM:508869) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Apollo Hospitals Enterprise Interest Expense Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apollo Hospitals Enterprise Interest Expense Chart
Apollo Hospitals Enterprise Interest Expense Calculation
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-4,496 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apollo Hospitals Enterprise (BOM:508869) has a Interest Expense of ₹-4,496 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Apollo Hospitals Enterprise and its competitors.
Is Apollo Hospitals Enterprise's Interest Expense too high?
Apollo Hospitals Enterprise's current Interest Expense is ₹-4,496 Mil. Overall, Apollo Hospitals Enterprise has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Apollo Hospitals Enterprise's Interest Expense compare to HCA and THC?
Apollo Hospitals Enterprise's Interest Expense of ₹-4,496 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Healthcare Providers & Services company?
A good Interest Expense depends on the Healthcare Providers & Services industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Apollo Hospitals Enterprise and its competitors. Apollo Hospitals Enterprise's current Interest Expense is ₹-4,496 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apollo Hospitals Enterprise stock overvalued right now?
Based on GuruFocus' analysis, Apollo Hospitals Enterprise (BOM:508869) is currently considered Fairly Valued. The stock's GF Value™ is ₹8,687.21, compared to a current price of ₹8,921.00 — trading 2.7% above its estimated fair value. The current Interest Expense is ₹-4,496 Mil. Apollo Hospitals Enterprise's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Apollo Hospitals Enterprise (BOM:508869), the current Interest Expense is ₹-4,496 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apollo Hospitals Enterprise (BOM:508869) Overvalued in 2026?
Based on GuruFocus' analysis, Apollo Hospitals Enterprise stock appears to be overvalued.
The current stock price of ₹8,921.00 is trading 2.7% above its estimated GF Value™ of ₹8,687.21.
GuruFocus considers Apollo Hospitals Enterprise to be Fairly Valued.
Key valuation signals for BOM:508869:
Interest Expense: ₹-4,496 Mil
GF Value™: ₹8,687.21 vs. price of ₹8,921.00 (2.7% above fair value)
No single metric tells the full story. See the BOM:508869 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. Its reportable operating segments are; Healthcare Services (represents hospitals and hospitals services); Retail Health and Diagnostics (includes clinics and diagnostics); Digital Health and Pharmacy Distribution; and Others. Maximum revenue is generated from its Healthcare Services segment.
83GF Score
Get the complete analysis for BOM:508869
Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:508869 has been successfully added to your 
